Cabozantinib enhances anti-PD1 efficacy and elicits a neutrophil-based immune response in murine models: implications for human HCC II

ABSTRACT: Cabozantinib enhances anti-PD1 efficacy and elicits a neutrophil-based immune response in murine models: implications for human HCC II

PROVIDER: PRJNA731499 | ENA |

REPOSITORIES: ENA